Revised International Staging System Applied to Real World Multiple Myeloma Patients

Recently, the Revised International Staging System (RISS) was introduced for clinical use and is being adopted by the International Myeloma Working Group. The RISS was developed using data from patients enrolled in clinical trials. To assess the effect of RISS in real world patients, we studied 381 patients with newly diagnosed multiple myeloma and confirmed the role of RISS in unselected nonclinical trial patients.

Source: Clinical Lymphoma, Myeloma and Leukemia - June 7, 2016 Category: Hematology Authors: Victor H. Jimenez-Zepeda, Peter Duggan, Paola Neri, Fariborz Rashid-Kolvear, Jason Tay, Nizar J. Bahlis Tags: Original Study Source Type: research